Advantage of Clean Clinical Trial Reference Data

This document is a technical report that discusses the significance of maintaining clean clinical trial reference data for biopharmaceutical companies. It outlines the challenges faced by organizations that rely on inconsistent and siloed systems for managing reference data, which can lead to operational inefficiencies and increased costs. The report details the hidden costs associated with poor data management, including the financial impact of manual data cleanup and delays in trial timelines. It emphasizes the need for a clean data strategy to support modern trial execution and advanced analytics, particularly in the context of increasing trial complexity and the industry's shift towards higher trial volumes. The report also presents solutions such as Veeva OpenData Clinical, which offers a verified directory of investigators and institutions to ensure data accuracy. By transitioning to a single source of truth, organizations can enhance operational efficiency and focus on strategic activities, ultimately accelerating drug development and improving patient outcomes.